InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by New Leaf Biopharma Opportunities II, L.P.. Officer active across 1 company, notably Harpoon Therapeutics, Inc.. Aggregated, 2 disclosures have been published. Breakdown: 1 buy · 0 sell. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations